These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29802556)

  • 1. In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model.
    van der Wildt B; Wilhelmus MMM; Beaino W; Kooijman EJM; Schuit RC; Bol JGJM; Breve JJP; Pasternack R; Lammertsma AA; Windhorst AD; Drukarch B
    EJNMMI Res; 2018 May; 8(1):39. PubMed ID: 29802556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase.
    van der Wildt B; Wilhelmus MM; Kooijman EJ; Jongenelen CA; Schuit RC; Büchold C; Pasternack R; Lammertsma AA; Drukarch B; Windhorst AD
    Nucl Med Biol; 2017 Jan; 44():90-104. PubMed ID: 27837727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of carbon-11 labeled acryl amides for selective PET imaging of active tissue transglutaminase.
    van der Wildt B; Wilhelmus MM; Bijkerk J; Haveman LY; Kooijman EJ; Schuit RC; Bol JG; Jongenelen CA; Lammertsma AA; Drukarch B; Windhorst AD
    Nucl Med Biol; 2016 Apr; 43(4):232-42. PubMed ID: 27067043
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ackermann U; Jäger L; Rigopoulos A; Burvenich IJG; O'Keefe GJ; Scott AM
    Nucl Med Biol; 2023; 116-117():108308. PubMed ID: 36502585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension.
    Liu C; Luo R; Wang W; Peng Z; Johnson GVW; Kellems RE; Xia Y
    Am J Hypertens; 2019 Apr; 32(5):476-485. PubMed ID: 30715101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.
    van der Wildt B; Lammertsma AA; Drukarch B; Windhorst AD
    Amino Acids; 2017 Mar; 49(3):585-595. PubMed ID: 27380031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of tissue transglutaminase.
    Keillor JW; Apperley KY; Akbar A
    Trends Pharmacol Sci; 2015 Jan; 36(1):32-40. PubMed ID: 25500711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
    Mehta K; Fok J; Miller FR; Koul D; Sahin AA
    Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
    Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
    J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
    Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
    Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
    Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines.
    Gallo M; Ferrari E; Terrazzan A; Brugnoli F; Spisni A; Taccioli C; Aguiari G; Trentini A; Volinia S; Keillor JW; Bergamini CM; Bianchi N; Pertinhez TA
    FEBS J; 2023 Nov; 290(22):5411-5433. PubMed ID: 37597264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
    Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
    J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
    Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
    Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction profiling of a set of acrylamide-based human tissue transglutaminase inhibitors.
    Jasim MH; Rathbone DL
    J Mol Graph Model; 2018 Jan; 79():157-165. PubMed ID: 29179065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P; Wang Z; Collighan RJ; Griffin M
    Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K
    Canella R; Brugnoli F; Gallo M; Keillor JW; Terrazzan A; Ferrari E; Grassilli S; Gates EWJ; Volinia S; Bertagnolo V; Bianchi N; Bergamini CM
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the development of tissue transglutaminase (TG2) inhibitors.
    Badarau E; Collighan RJ; Griffin M
    Amino Acids; 2013 Jan; 44(1):119-27. PubMed ID: 22160259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.